The healthcare industry is seeing a significant shift in blood sugar therapy with the arrival of GLP-1 transdermal devices. These groundbreaking delivery systems offer a potentially convenient option to injections for individuals living with type 2 diabetes. By bypassing the necessity for frequent needles, GLP-1 skin devices promise to improve pati